Proton therapy, one of the most promising advanced forms of cancer therapy, is linked to numerous benefits and favorable outcomes. Yet it is only being used on less than five percent of radiotherapy patients. Fortunately, institutions like Baptist Health’s Miami Cancer Institute, are recognizing its tremendous value and partnering with IBA to ensure more patients have access to this innovative treatment. As the video explains, doctors at the Miami Cancer Institute have been using IBA’s state-of-the-art technology to treat patients since 2017. The video features Emma-Jane Hinton, the Center’s 1000th proton therapy patient. Emma’s mother, Esther Martinez, explains the limited treatment options her daughter faced after being diagnosed with a germinoma brain tumor in June 2020. Now 15 and in high school, Emma describes her gratitude at being able to “get back to doing everything I did before if not more” and “getting a move on.” Says Esther: “I can’t express how grateful I am. The experience was amazing. The treatment was amazing. The people were amazing. Every family should have an opportunity for this therapy.”
IBA's role as the global market leader in proton therapy is driven by its unwavering commitment to making this transformative treatment accessible to all who can benefit from it. Through strategic partnerships, advocacy efforts, technological advancements, and global knowledge-sharing, IBA is pioneering the way forward, revolutionizing cancer care, and providing hope to patients worldwide. IBA is shaping a future where proton therapy is universally accessible, saving lives and improving outcomes for countless individuals like Emma-Jane.